Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia (Q42361917)
Jump to navigation
Jump to search
scientific article published on 12 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia |
scientific article published on 12 January 2017 |
Statements
1 reference
Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia (English)
1 reference
Monika Brüggemann
1 reference
Gerhard Zugmaier
1 reference
Matthias Klinger
1 reference
Peter Kufer
1 reference
Matthias Stelljes
1 reference
Andreas Viardot
1 reference
Heinz A Horst
1 reference
Svenja Neumann
1 reference
Oliver G Ottmann
1 reference
Dorothea Wessiepe
1 reference
Max S Topp
1 reference
Ralf Bargou
1 reference
12 January 2017
1 reference
1 reference
102
1 reference
e132-e135
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference